Sign up to save your podcasts
Or
Share Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors
Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society’s 67th Annual Scientific Meeting in June 2025.
Show reference:
https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society’s 67th Annual Scientific Meeting in June 2025.
Show reference:
https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957
More shows like Neurology Minute
View all
JAMA Clinical Reviews
498 Listeners
Neurology® Podcast
294 Listeners
Practical Neurology Podcast
51 Listeners
Mayo Clinic Talks
288 Listeners
The Curbsiders Internal Medicine Podcast
3,337 Listeners
Emergency Medical Minute
260 Listeners
JAMA Neurology Author Interviews
13 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Short Wave
6,362 Listeners
Neurology Exam Prep Podcast
180 Listeners
The Curious Clinicians
370 Listeners
Continuum Audio
79 Listeners